InvestorsHub Logo
Followers 33
Posts 2288
Boards Moderated 0
Alias Born 10/13/2010

Re: None

Wednesday, 08/16/2023 8:41:13 AM

Wednesday, August 16, 2023 8:41:13 AM

Post# of 64560
TSOI reported today successfully generation of a quality control tested Master Cell Bank comprised of its JadiCell universal donor stem cell product. Prior to this, the Company relied on third party manufacturing, which carried significantly more costs as well as potential regulatory uncertainty. The recently generated cells possessed both functional and phenotypic characteristics that the FDA has agreed to in its clearance of the Company to conduct a Phase III clinical trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News